XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non- controlling Interests
Beginning balances at Dec. 31, 2019 $ 663,054 $ 1,707 $ 1,501 $ 338,507 $ 370,477 $ 1,707 $ (43,564) $ (5,279) $ 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 53,711       53,610       101
Other comprehensive income (loss) 19,700           19,700    
Subtotal comprehensive income attributable to noncontrolling interests and Tompkins Financial Corporation 73,411                
Cash dividends (23,296)       (23,296)        
Net exercise of stock options (248)     (248)          
Common stock repurchased and returned to unissued status (5,620)   (7) (5,613)          
Shares issued for dividend reinvestment plan 1,529   2 1,527          
Stock-based compensation expense 3,372     3,372          
Directors deferred compensation plan 0     76       (76)  
Restricted stock activity (292)     (292)          
Partial repurchase of noncontrolling interest (6)               (6)
Ending balances at Sep. 30, 2020 713,611   1,496 337,329 402,498   (23,864) (5,355) 1,507
Beginning balances at Jun. 30, 2020 698,029   1,495 335,268 386,025   (21,048) (5,187) 1,476
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 24,262       24,230       32
Other comprehensive income (loss) (2,816)           (2,816)    
Subtotal comprehensive income attributable to noncontrolling interests and Tompkins Financial Corporation 21,446                
Cash dividends (7,757)       (7,757)        
Net exercise of stock options (32)   0 (32)          
Shares issued for dividend reinvestment plan 848   1 847          
Stock-based compensation expense 1,078     1,078          
Directors deferred compensation plan 0     168       (168)  
Restricted stock activity 0     0          
Partial repurchase of noncontrolling interest (1)               (1)
Ending balances at Sep. 30, 2020 713,611   1,496 337,329 402,498   (23,864) (5,355) 1,507
Beginning balances at Dec. 31, 2020 717,689   1,496 333,976 418,413   (32,074) (5,534) 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 69,895       69,799       96
Other comprehensive income (loss) (23,020)           (23,020)    
Subtotal comprehensive income attributable to noncontrolling interests and Tompkins Financial Corporation 46,875                
Cash dividends (24,060)       (24,060)        
Net exercise of stock options (693)   1 (694)          
Common stock repurchased and returned to unissued status (21,177)   (27) (21,150)          
Shares issued for dividend reinvestment plan 2   0 2          
Stock-based compensation expense 3,845     3,845          
Directors deferred compensation plan 0     100       (100)  
Restricted stock activity (122)     (122)          
Partial repurchase of noncontrolling interest (2)               (2)
Ending balances at Sep. 30, 2021 722,357   1,470 315,957 464,152   (55,094) (5,634) 1,506
Beginning balances at Jun. 30, 2021 728,253   1,487 327,881 450,773   (47,882) (5,480) 1,474
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 21,374       21,342       32
Other comprehensive income (loss) (7,212)           (7,212)    
Subtotal comprehensive income attributable to noncontrolling interests and Tompkins Financial Corporation 14,162                
Cash dividends (7,963)       (7,963)        
Net exercise of stock options (190)   (190)          
Common stock repurchased and returned to unissued status (13,194)   (17) (13,177)          
Stock-based compensation expense 1,411     1,411          
Directors deferred compensation plan 0     154       (154)  
Restricted stock activity (122)     (122)          
Ending balances at Sep. 30, 2021 $ 722,357   $ 1,470 $ 315,957 $ 464,152   $ (55,094) $ (5,634) $ 1,506